Bio-Techne Corp. (TECH)

197.86
NASDAQ : Health Technology
Prev Close 202.04
Day Low/High 196.67 / 200.93
52 Wk Low/High 132.75 / 207.84
Avg Volume 153.50K
Exchange NASDAQ
Shares Outstanding 37.87M
Market Cap 7.65B
EPS 3.40
P/E Ratio 63.34
Div & Yield 1.28 (0.64%)

Latest News

Roche Expands Partnership With Bio-Techne To Offer Drug Discovery Researchers New Chromogenic Detection Options For MRNA ISH Tissue Analysis

Roche Expands Partnership With Bio-Techne To Offer Drug Discovery Researchers New Chromogenic Detection Options For MRNA ISH Tissue Analysis

New Roche detection kits, combined with Bio-Techne's ACD RNAscope® reagent kits, increase singleplex and multiplex testing capabilities on automated platform

Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

MINNEAPOLIS, May 2, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Wednesday, May 15 th, 2019, at 2:20 p.

Bio-Techne Declares Dividend

Bio-Techne Declares Dividend

MINNEAPOLIS, April 30, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.

Bio-Techne Releases Third Quarter Fiscal 2019 Results

Bio-Techne Releases Third Quarter Fiscal 2019 Results

MINNEAPOLIS, April 30, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2019.

Elpiscience And Bio-Techne Announce Strategic Collaboration

Elpiscience And Bio-Techne Announce Strategic Collaboration

SHANGHAI and MINNEAPOLIS, April 22, 2019 /PRNewswire/ --  Elpiscience BioPharma and Bio-Techne Corporation announced today that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics.

Bio-Techne To Host Conference Call On April 30, 2019 To Announce Third Quarter 2019 Financial Results

Bio-Techne To Host Conference Call On April 30, 2019 To Announce Third Quarter 2019 Financial Results

MINNEAPOLIS, April 9, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, April 30, 2019 at 8:00 a.

Bio-Techne And NanoString Partner To Co-Develop Integrated Workflow For RNA Spatial Profiling

Bio-Techne And NanoString Partner To Co-Develop Integrated Workflow For RNA Spatial Profiling

-- Integrated Workflow Combines NanoString's GeoMx DSP High-Plex RNA Assays and Bio-Techne's Highly Sensitive RNAscope Imaging Reagent Portfolio --

Bio-Techne Scores A Trio Of CiteAb 2019 Awards

Bio-Techne Scores A Trio Of CiteAb 2019 Awards

MINNEAPOLIS, March 5, 2019 /PRNewswire/ -- Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, was honored with three prestigious 2019 CiteAb Awards.

Bio-Techne To Present At The Barclays Global Healthcare Conference

Bio-Techne To Present At The Barclays Global Healthcare Conference

MINNEAPOLIS, March 5, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer will present at the Barclays Global Healthcare Conference on Wednesday, March 13 th, 2019, at 9:00 a.

Bio-Techne Signs Strategic Cooperation Agreement With Lisen Imprinting Diagnostics

Bio-Techne Signs Strategic Cooperation Agreement With Lisen Imprinting Diagnostics

MINNEAPOLIS, Feb. 26, 2019 /PRNewswire/ -- Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co.

Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference

MINNEAPOLIS, Feb. 20, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer will present at the 8 th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27...

Bio-Techne Declares Dividend

Bio-Techne Declares Dividend

MINNEAPOLIS, Feb. 5, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.

Bio-Techne Releases Second Quarter Fiscal 2019 Results

Bio-Techne Releases Second Quarter Fiscal 2019 Results

MINNEAPOLIS, Feb. 5, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2018.

ExoDx® Prostate(IntelliScore) (EPI) Recommended In National Comprehensive Cancer Network Guidelines For Prostate Cancer Early Detection

ExoDx® Prostate(IntelliScore) (EPI) Recommended In National Comprehensive Cancer Network Guidelines For Prostate Cancer Early Detection

MINNEAPOLIS, Jan. 31, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the National Comprehensive Cancer Network (NCCN) decision to include EPI as a recommended test in their Clinical Practice Guidelines in Oncology (NCCN...

Bio-Techne Introduces 48-Digoxigenin Cartridge For The Ella Platform

Bio-Techne Introduces 48-Digoxigenin Cartridge For The Ella Platform

MINNEAPOLIS, Jan. 29, 2019 /PRNewswire/ -- Bio-Techne today announced the launch of a new customizable cartridge format for their ProteinSimple-branded Ella™ immunoassay platform.

Bio-Techne Introduces CE-SDS PLUS For Maurice™ System

Bio-Techne Introduces CE-SDS PLUS For Maurice™ System

MINNEAPOLIS, Jan. 28, 2019 /PRNewswire/ -- Bio-Techne today announced the launch of the CE-SDS PLUS system for its ProteinSimple-branded Maurice ™ platform.

Bio-Techne Launches Cell And Gene Therapy Portfolio

Bio-Techne Launches Cell And Gene Therapy Portfolio

MINNEAPOLIS, Jan. 24, 2019 /PRNewswire/ -- Bio-Techne announces the launch of their cell and gene therapy portfolio.

Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results

Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results

MINNEAPOLIS, Jan. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, February 5, 2019, at 8:00 a.

Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference

Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 20, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer will present at the 37 th Annual J.

Bio-Techne Releases GMP ROCK Inhibitor And CHIR 99021 For Stem Cell Therapy

Bio-Techne Releases GMP ROCK Inhibitor And CHIR 99021 For Stem Cell Therapy

MINNEAPOLIS, Dec. 4, 2018 /PRNewswire/ -- Bio-Techne has further added to its cell therapy portfolio by expanding the range of Tocris Bioscience-branded cGMP small molecules to include the commonly used stem cell compounds, Y-27632 (ROCK inhibitor) and...

Trade Wars: Winners & Losers for Investors

Trade Wars: Winners & Losers for Investors

Argus Research details 24 stocks likely to be impacted, one way or the other, by trade wars and tariffs.

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

After acquiring Amsterdam-based Patheon, TMO will continue its focus on collecting future companies into its back pocket.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANH, DVN, EXEL, FMC, FSI, GLT, MEOH, MJCO, MOH, NVO, RPXC, TECH, WU, WWE Downgrades: CIGI, IPHI, QUOT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Here's a Look at 5 Stocks to Avoid

Here's a Look at 5 Stocks to Avoid

After the bullish run stocks have enjoyed for the last year, you'd better get your guard up.

A Very Large Chunk of the Stock Market Has Gone Nowhere -- So Here Is What You Should Do

A Very Large Chunk of the Stock Market Has Gone Nowhere -- So Here Is What You Should Do

These are the five stocks to play.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALLE, AXP, FSIC, ISRL, LCUT, NRZ, SID Downgrades: DAVE, HIL, IRS, KCG, PROV, TECH Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Bio-Techne (TECH) Showing Signs Of Being Strong And Under The Radar

Bio-Techne (TECH) Showing Signs Of Being Strong And Under The Radar

Trade-Ideas LLC identified Bio-Techne (TECH) as a strong and under the radar candidate

Trade-Ideas: Bio-Techne (TECH) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas: Bio-Techne (TECH) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Bio-Techne (TECH) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

TheStreet Quant Rating: B+ (Buy)